Azenta EVP Lin buys $69,900 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Azenta Inc (AZTA)
Azenta Inc stock price live, this page displays NASDAQ AZTA stock exchange data. View the AZTA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Azenta Inc real time stock price chart below.
What Is the Azenta Inc Stock Price Today?
The Azenta Inc stock price today is 30.39.
What Is the Stock Symbol for Azenta Inc?
The stock symbol for Azenta Inc is ""AZTA.""
What Stock Exchange Does Azenta Inc Trade On?
Azenta Inc is listed and trades on the NASDAQ stock exchange.
Is Azenta Inc a Good Stock to Buy?
Determining whether Azenta Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZTA quote. (ISIN: US1143401024)
What Is the Azenta Inc Stock Price Today?
The Azenta Inc stock price today is 30.39.
What Is the Stock Symbol for Azenta Inc?
The stock symbol for Azenta Inc is ""AZTA.""
What Stock Exchange Does Azenta Inc Trade On?
Azenta Inc is listed and trades on the NASDAQ stock exchange.
Is Azenta Inc a Good Stock to Buy?
Determining whether Azenta Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZTA quote. (ISIN: US1143401024)
NASDAQ
Currency in USD
Fair Value
An estimate of a Azenta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.76
31.13
52 wk Range
23.91
55.63
AZTA Scorecard
Full Analysis
Management has been aggressively buying back shares
AZTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Azenta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.7631.13
52 wk Range
23.9155.63
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AZTA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Azenta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
33.00
Upside
+8.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Brooks Automation receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Azenta EVP Lin buys $69,900 in shares
- Investing.com
- Brooks Automation receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Azenta Inc Company Profile
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Azenta Inc Earnings Call Summary for Q3/2025
- Azenta's Q3 2025 non-GAAP EPS of $0.19 beat expectations by 46.15%, but revenue of $144M missed forecasts by 3.69%
- Stock dropped 15.13% to $32.41 despite pre-market rise, reflecting investor concerns amid broader market pressures
- Company reaffirmed FY2025 organic revenue growth guidance of 3-5%, expecting Q4 revenue around $160M
- Strong momentum in Next Generation Sequencing (NGS) noted; focus on long-term profitable growth and efficient capital management
- Challenges include funding constraints in life sciences, geopolitical uncertainties, and potential NIH funding headwinds
Last Updated: 05/08/2025, 16:40
Read Full TranscriptCompare AZTA to Peers and Sector
Metrics to compare | AZTA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAZTAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.3x | −0.8x | −0.5x | |
PEG Ratio | −0.64 | 0.00 | 0.00 | |
Price/Book | 0.8x | 1.1x | 2.6x | |
Price / LTM Sales | 2.1x | 2.1x | 3.3x | |
Upside (Analyst Target) | 2.9% | 106.1% | 40.3% | |
Fair Value Upside | Unlock | 14.8% | 5.1% | Unlock |
Analyst Ratings
2 Buy
5 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 33.00
(+8.59% Upside)
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
0.19 / 0.13
Revenue / Forecast
144.00M / 149.51M
People Also Watch
FAQ
What Stock Exchange Does Azenta Trade On?
Azenta is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Azenta?
The stock symbol for Azenta is "AZTA."
What Is the Azenta Market Cap?
As of today, Azenta market cap is 1.39B.
What Is Azenta's Earnings Per Share (TTM)?
The Azenta EPS (TTM) is -3.62.
When Is the Next Azenta Earnings Date?
Azenta will release its next earnings report on 17 Nov 2025.
From a Technical Analysis Perspective, Is AZTA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Azenta Stock Split?
Azenta has split 0 times.
How Many Employees Does Azenta Have?
Azenta has 3000 employees.
What is the current trading status of Azenta (AZTA)?
As of 16 Aug 2025, Azenta (AZTA) is trading at a price of 30.39, with a previous close of 30.59. The stock has fluctuated within a day range of 29.76 to 31.13, while its 52-week range spans from 23.91 to 55.63.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.